ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
Karin Enell Smith(Alligator Bioscience (Sweden)), Peter Ellmark(Lund University)
Cited by 8
Related Papers
No related papers found
Powered by citation graph analysis